| 000 | 02599 a2200841 4500 | ||
|---|---|---|---|
| 005 | 20250515184023.0 | ||
| 264 | 0 | _c20091001 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1468-3083 | ||
| 024 | 7 |
_a10.1111/j.1468-3083.2009.03389.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPathirana, D | |
| 245 | 0 | 0 |
_aEuropean S3-guidelines on the systemic treatment of psoriasis vulgaris. _h[electronic resource] |
| 260 |
_bJournal of the European Academy of Dermatology and Venereology : JEADV _cOct 2009 |
||
| 300 |
_a1-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAlefacept |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aCyclosporine _xadverse effects |
| 650 | 0 | 4 |
_aDermatologic Agents _xadverse effects |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadverse effects |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aMethotrexate _xadverse effects |
| 650 | 0 | 4 |
_aPUVA Therapy _xadverse effects |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xadverse effects |
| 650 | 0 | 4 |
_aRetinoids _xadverse effects |
| 700 | 1 | _aOrmerod, A D | |
| 700 | 1 | _aSaiag, P | |
| 700 | 1 | _aSmith, C | |
| 700 | 1 | _aSpuls, P I | |
| 700 | 1 | _aNast, A | |
| 700 | 1 | _aBarker, J | |
| 700 | 1 | _aBos, J D | |
| 700 | 1 | _aBurmester, G-R | |
| 700 | 1 | _aChimenti, S | |
| 700 | 1 | _aDubertret, L | |
| 700 | 1 | _aEberlein, B | |
| 700 | 1 | _aErdmann, R | |
| 700 | 1 | _aFerguson, J | |
| 700 | 1 | _aGirolomoni, G | |
| 700 | 1 | _aGisondi, P | |
| 700 | 1 | _aGiunta, A | |
| 700 | 1 | _aGriffiths, C | |
| 700 | 1 | _aHönigsmann, H | |
| 700 | 1 | _aHussain, M | |
| 700 | 1 | _aJobling, R | |
| 700 | 1 | _aKarvonen, S-L | |
| 700 | 1 | _aKemeny, L | |
| 700 | 1 | _aKopp, I | |
| 700 | 1 | _aLeonardi, C | |
| 700 | 1 | _aMaccarone, M | |
| 700 | 1 | _aMenter, A | |
| 700 | 1 | _aMrowietz, U | |
| 700 | 1 | _aNaldi, L | |
| 700 | 1 | _aNijsten, T | |
| 700 | 1 | _aOrtonne, J-P | |
| 700 | 1 | _aOrzechowski, H-D | |
| 700 | 1 | _aRantanen, T | |
| 700 | 1 | _aReich, K | |
| 700 | 1 | _aReytan, N | |
| 700 | 1 | _aRichards, H | |
| 700 | 1 | _aThio, H B | |
| 700 | 1 | _avan de Kerkhof, P | |
| 700 | 1 | _aRzany, B | |
| 773 | 0 |
_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 23 Suppl 2 _gp. 1-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-3083.2009.03389.x _zAvailable from publisher's website |
| 999 |
_c19113613 _d19113613 |
||